Available Carbohydrates, Glycemic Load, and Pancreatic Cancer: is There a Link?
Overview
Authors
Affiliations
High-carbohydrate diets have been linked to pancreatic cancer risk in case-control studies, but prospective studies have shown mostly null results. The authors investigated the associations of glycemic load, glycemic index, and carbohydrate intake with pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Dietary intake was assessed by using a self-administered questionnaire. Between 1998 and 2006 (median follow-up = 6.5 years), 266 incident, confirmed pancreatic cancers were identified among 109,175 participants. Hazards ratios and 95% confidence intervals were adjusted for sex, smoking, body mass index, and total energy. Overall, elevated risks for pancreatic cancer were observed in the 90th versus 10th percentile of glycemic load (hazards ratio (HR) = 1.45, 95% confidence interval (CI): 1.05, 2.00), available carbohydrate (HR = 1.47, 95% CI: 1.05, 2.06), and sucrose (HR = 1.37, 95% CI: 0.99, 1.89) intake. The positive association for available carbohydrate intake was observed during the first 4 years of follow-up (HR(<2 years) = 2.60, 95% CI: 1.34, 5.06; HR(2-<4 years) = 1.94, 95% CI: 1.06, 3.55) but not subsequently (HR = 0.86, 95% CI: 0.52, 1.44); the opposite pattern was observed for total fat and saturated fat intake. Rather than being causal, the short-term increase in pancreatic cancer risk associated with high available carbohydrate and low fat intake may be capturing dietary changes associated with subclinical disease.
Maternal insulinemic and inflammatory dietary patterns and risk of child neurodevelopmental delay.
Wang H, Zu P, Yin W, Zhang L, Ruan L, Chen X Eur J Nutr. 2024; 64(1):25.
PMID: 39589432 DOI: 10.1007/s00394-024-03531-7.
Donghia R, Guerra V, Misciagna G, Loiacono C, Brunetti A, Bevilacqua V Front Oncol. 2023; 13:1110999.
PMID: 37168368 PMC: 10166229. DOI: 10.3389/fonc.2023.1110999.
What Dietary Patterns and Nutrients are Associated with Pancreatic Cancer? Literature Review.
Ibrahim M, Abuhijleh H, Tayyem R Cancer Manag Res. 2023; 15:17-30.
PMID: 36643074 PMC: 9832506. DOI: 10.2147/CMAR.S390228.
Jin Q, Hart P, Shi N, Joseph J, Donneyong M, Conwell D Cancer Epidemiol Biomarkers Prev. 2021; 30(6):1229-1240.
PMID: 33827986 PMC: 8172436. DOI: 10.1158/1055-9965.EPI-20-1478.
Jin Q, Shi N, Aroke D, Lee D, Joseph J, Donneyong M Diabetes Care. 2021; 44(3):707-714.
PMID: 33419931 PMC: 7896263. DOI: 10.2337/dc20-2216.